The 2022 Annual Shareholders’ Meeting passes release the prohibition on directors from participation in competition businesses.

 

SEQ_NO  3 Date of announcement 2022/06/21 Time of announcement 21:59:48
Subject
The 2022 Annual Shareholders' Meeting passes
release the prohibition on directors from participation
in competition businesses.
Date of events 2022/06/21 To which item it meets paragraph 21
Statement
1.Date of the shareholders meeting resolution:2022/06/21
2.Name and title of the director with permission to 
  engage in competitive conduct:
  Director:Fu Hui-Tung
  Director:Chang Ming-Cheng
  Director:Hsieh Yen-Sheng
  Director:Excelsior Group Holdings Co., Ltd. 
  Representative:Chen Tun-Ling
  Director:Excelsior Group Holdings Co., Ltd. 
  Representative:Chang Hsien-Cheng
  Director:Fu Jo-Hsuan
  Independent director:Chang Wu-I
  Independent director:Kuo Yu-Chia
  Independent director:Jhan Cian-Long
3.Items of competitive conduct in which the director 
  is permitted to engage:
  Concurrently serve as a director with the same or 
  similar business scope as the Company.
4.Period of permission to engage in the competitive 
  conduct: A director's term of office
5.Circumstances of the resolution (please describe the 
  results of voting in accordance with Article 209 of 
  the Company Act): 
  The resolution was adopted by a majority of the 
  shareholders presented at the general meeting who
  represented two-thirds or more of the total number
  of shares represented by the attending shareholders.
6.If the permitted competitive conduct belongs to the 
  operator of a mainland China area enterprise, the 
  name and title of the directors
  (if it is not the operator of a Mainland-area 
   enterprise,please enter “N/A” below):
   Director:Fu Hui-Tung
   Director:Fu Jo-Hsuan
7.Company name of the mainland China area enterprise 
  and the director's position in the enterprise:
  Director:Fu Hui-Tung,Director of SinoExcelsior 
  Investment Incorporation.
  Director:Fu Jo-Hsuan,Director of SinoExcelsior 
  Investment Incorporation.
8.Address of the mainland China area enterprise:
  SinoExcelsior Investment Incorporation address:
  Room 301-2, No.1089, Kang Ning Lu, Shanghai Shi, China
9.Operations of the mainland China area enterprise:
  enterprise management consulting, business information 
  consulting,technical consulting and technical services 
  in the professional field of medical technology (except
  for the development and application of human stem 
  cells,gene diagnosis and treatment technology), and 
  wholesale of cosmetics , import and export, beauty 
  shop, barber shop (limited to branch operations).
10.Impact on the company's finance and business:None.
11.If the directors have invested in the mainland China
   area enterprise,the monetary amount of the investment
   and their shareholding ratio:None.
12.Any other matters that need to be specified:None.